Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.08. | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
20.08. | Tivic Health receives two INDs for Entolimod from Statera Biopharma | 2 | Investing.com | ||
TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
20.08. | Tivic Health sichert sich zwei IND-Anträge für Medikamentenkandidaten Entolimod | 12 | Investing.com Deutsch | ||
20.08. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
15.08. | Tivic Health stock soars as company advances military radiation countermeasure | 3 | Investing.com | ||
15.08. | Tivic Health: Aktie schießt nach Fortschritten bei militärischem Strahlenschutz in die Höhe | 2 | Investing.com Deutsch | ||
15.08. | Tivic Health signals exit from consumer health tech while advancing $19B+ immunotherapy market pipeline | 3 | Seeking Alpha | ||
14.08. | Earnings Call: Tivic Health meldet für Q2 2025 Umsatzrückgang und strategische Neuausrichtung | 1 | Investing.com Deutsch | ||
14.08. | Tivic Health Systems, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
08.08. | Tivic Health registers 400K shares for resale linked to Statera License deal | 5 | Seeking Alpha | ||
25.07. | Tivic Health Systems, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
25.07. | Tivic Health Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
08.07. | Tivic Health stock rises after shareholders approve strategic proposals | 1 | Investing.com | ||
07.07. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
25.06. | Tivic Health Systems, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
06.06. | Tivic Health Systems files to sell 8.44M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
06.06. | Tivic Health Systems, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
22.05. | Tivic Health Systems, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
16.05. | Tivic Health signals strategic transformation with $8.4M financing and biopharma focus amid market repositioning | 1 | Seeking Alpha | ||
15.05. | Tivic Health Systems, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,112 | -0,88 % | Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference | ||
ATOSSA THERAPEUTICS | 0,680 | -0,44 % | Atossa Genetics stock rating reiterated by H.C. Wainwright on FDA meeting plans | ||
PING AN HEALTHCARE | 2,516 | +1,49 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,260 | -0,76 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
VERU | 3,820 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
CYTOSORBENTS | 0,853 | +5,96 % | CytoSorbents bei H.C. Wainwright: Strategisches Wachstum und regulatorische Herausforderungen | ||
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
VOLITIONRX | 0,631 | 0,00 % | H.C. Wainwright bestätigt Kaufempfehlung für VolitionRX nach Partnerschaft mit Werfen | ||
EKSO BIONICS | 4,070 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 4,900 | +2,51 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BEYOND AIR | 2,260 | 0,00 % | Beyond Air, Inc. - 8-K, Current Report | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
NOVACYT | 0,449 | -5,87 % | Novacyt S.A. - Liquidity Agreement Monthly Update and TVR | ||
AROVELLA THERAPEUTICS | 0,041 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: 2025 ESG Report |